Last reviewed · How we verify
Fraxiparin (NADROPARIN CALCIUM)
Fraxiparin (generic name: NADROPARIN CALCIUM) is a drug. It is currently FDA-approved (first approved 2018) for Deep venous thrombosis.
Fraxiparin is a low molecular weight heparin (LMWH) used for thrombosis prophylaxis and treatment of conditions such as Deep Venous Thrombosis and Pulmonary Embolism. It works as an Antithrombin-III activator, a mechanism that involves activating the protein Antithrombin-III to inhibit blood clotting.
At a glance
| Generic name | NADROPARIN CALCIUM |
|---|---|
| Modality | Oligosaccharide |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
| First approval | 2018 |
Approved indications
- Deep venous thrombosis
Common side effects
Key clinical trials
- Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis (PHASE3)
- Reduced Anticoagulation Targets in ECLS (RATE) (PHASE3)
- Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT） (PHASE4)
- Leiden Trial in Prevention of Post-Operative ThromboEmbolic Events (NA)
- The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity (PHASE3)
- Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine (PHASE2)
- Kinetics of Extracellular Vesicles in Hemodialysis
- Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fraxiparin CI brief — competitive landscape report
- Fraxiparin updates RSS · CI watch RSS
Frequently asked questions about Fraxiparin
What is Fraxiparin?
What is Fraxiparin used for?
What is the generic name of Fraxiparin?
When was Fraxiparin approved?
What development phase is Fraxiparin in?
Related
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Deep venous thrombosis
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing